A Pilot Study of Short-Duration Hyperbaric Oxygen Therapy to Improve HbA1c, Leukocyte, and Serum Creatinine in Patients with Diabetic Foot Ulcer Wagner 3-4

Table 1

Characteristics of patients.

Variables	Standard therapy	Standard therapy + HBOT
	(n=15)	(n=15)
Age (years old)	56.67 ± 8.30	50.53 ± 7.52
Duration of DFU	3.34 ± 2.09	6.07 ± 4.13
Duration of DM	4 (1-10)	3 (0.17-25)
Body mass index	22.04 (14.33-36.73)	22.04 (17.58-29.40)
Sex (%)
Male	4 (26.7)	8 (53.3)
Female	11 (73.3)	7 (46.7)
Smoking (%)
Yes	1 (6.7)	3 (20)
No	14 (93.3)	12 (80)
Hypertension (%)
Yes	6 (40)	6 (40)
No	9 (60)	9 (60)
Ulcer classification (%)
Wagner 3	8 (53.3)	6 (40)
Wagner 4	7 (46.7)	9 (60)
Surgery (%)
Debridement	9 (60)	9 (60)
Debridement with toe amputation	6 (40)	6 (40)
Hemoglobin
Baseline	10.47 ± 1.72	10.34 ± 1.55
After 2 weeks	9.45 ± 1.46	11.04 ± 1.47
Albumin
Baseline	3.00 ± 0.56	3.08 ± 0.78
After 2 weeks	3.07 ± 0.53	3.59 ± 0.76

deviation; (range).